Health ❯ Healthcare ❯ Oncology

Prostate Cancer

Diagnosis Treatment Metastatic Castration Sensitive Prostate Cancer Androgen Ablation Therapy Clinical Trials Treatment Options Symptoms Hormonal Therapy Diagnosis Methods Metastatic Disease MRI Utilization Biomarkers Patient Care BRCA Mutations FDA Approved Drugs PTEN-deficient Tumors Salvage Radiotherapy Metastatic Hormone-Sensitive Prostate Cancer Metastatic Castration-Resistant Prostate Cancer Research Research Studies Psychological Impact Enzalutamide CDK12/13 Inactivation Survival Rates Surgical Treatment Risk Factors Technological Advances Hormone-Sensitive Prostate Cancer Screening Methods Localized Prostate Cancer VIR-5500

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

The split votes highlight regulators' push for proof that early treatment changes extend lives.

Pfizer’s Talzenna Plus Xtandi Delivers Phase 3 Win in Hormone-Sensitive Prostate Cancer

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

Final EMBARK Results Show 40% Lower Mortality With Enzalutamide Plus Leuprolide in High-Risk Recurrent Prostate Cancer

CDK12/13 Degraders Activate STING-Mediated Immunity and Enhance Checkpoint Therapy